Skip to main content
Fig. 4 | Radiation Oncology

Fig. 4

From: Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study

Fig. 4

Forest plot of PFS A and OS B in subgroups of patients. RT Radiotherapy; PD1 Monoclonal antibody against programmed cell death; TACE Transcatheter arterial chemoembolization; OS Overall survival; PFS Progression-free survival; HBV Hepatitis B; BCLC Barcelona Clinic Liver Cancer; AFP Alpha-fetoprotein

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us